Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of cause-of-death statistics in urban China.
Rao C, Yang G, Hu J, Ma J, Xia W, Lopez AD. Rao C, et al. Among authors: xia w. Int J Epidemiol. 2007 Jun;36(3):642-51. doi: 10.1093/ije/dym003. Epub 2007 Feb 28. Int J Epidemiol. 2007. PMID: 17329316
Smoking among rural and urban young women in China.
Ho MG, Ma S, Chai W, Xia W, Yang G, Novotny TE. Ho MG, et al. Among authors: xia w. Tob Control. 2010 Feb;19(1):13-8. doi: 10.1136/tc.2009.030981. Epub 2009 Oct 11. Tob Control. 2010. PMID: 19822528 Free PMC article.
Development and validation of a prognostic nomogram incorporating neutrophil-to-albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
Hua X, Wang MD, Ni WQ, Long ZQ, Wang SF, Duan FF, Zhang C, Huang X, Xu F, Xia W, Chen JY, Gao YS. Hua X, et al. Among authors: xia w. Heliyon. 2024 Dec 3;11(1):e40881. doi: 10.1016/j.heliyon.2024.e40881. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39801974 Free PMC article.
A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer.
Zhong Y, Li T, Bai Z, Qiu N, Liu S, Xia W, Wei Q, Chen L. Zhong Y, et al. Among authors: xia w. Recent Pat Anticancer Drug Discov. 2025 Jan 6. doi: 10.2174/0115748928304000240429120252. Online ahead of print. Recent Pat Anticancer Drug Discov. 2025. PMID: 39779562 Clinical Trial.
5,436 results